Trial Profile
Efficacy of Humira(Adalimumab) in patients with moderate to severe ulcerative colitis (KyuSyu IBD project)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 May 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms HAWKS study
- 02 Nov 2015 New trial record